Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT - Taxus Pharmaceuticals, Inc. | forms1amendment.htm |
| EX-5 - US LEGAL OPINION - Taxus Pharmaceuticals, Inc. | ex51uslegalopinion.htm |
| EX-23 - AUDITOR CONSENT - Taxus Pharmaceuticals, Inc. | ex231auditorconsent.htm |
| EX-5 - CONSENT BY CHINESE LEGAL COUNSEL - Taxus Pharmaceuticals, Inc. | ex53chineselegalconsent.htm |
| EX-5 - CHINESE LEGAL OPINION - Taxus Pharmaceuticals, Inc. | ex52chineselegalopinion.htm |
| EX-99 - FINANCIAL STATEMENTS AND FOOTNOTES (MARCH 31, 2013 AND 2012) - Taxus Pharmaceuticals, Inc. | ex992taxusfs_march312013.htm |
| EX-99 - FINANCIAL STATEMENTS AND FOOTNOTES (DEC. 31, 2012 AND 2011) - Taxus Pharmaceuticals, Inc. | ex991taxuspharmaceuticals_de.htm |
English Translation of
Letter of Commitment
Shanxi Hongshan Pharmaceuticals Co., Ltd:
Since Shanxi Hongshan Pharmaceuticals Co., Ltd (“Company”) is in the early stage of business research and production development, It is in a shortage of funds. I, as the Company’s legal representative, has been continually loaned funds to the Company. As of 12/31/2011, the outstanding balance was RMB22,399,766.02 ($3,525,723). I promise that this is an interest-free long-term loan for two years from 01/01/2012 to 12/31/2013, used for the Company’s cash flow.
At the same time, I promise to continue to provide necessary funds whenever needed to ensure the Company’s continued development.
Hereby undertake.
Jiayue Zhang
01/01/2012